Month: July 2024

Psyence Group’s NASDAQ-Listed Associate, Psyence Biomedical, Announces Export of Nature-Derived Psilocybin to Australia and Provides Update on Upcoming Phase IIb Trial

NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) — Psyence Group Inc (“Psyence Group“) (CSE: PSYG), a life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing, is pleased to announce that its NASDAQ-listed associate, Psyence Biomedical Ltd (NASDAQ: PBM) (“PBM” or “Psyence Biomed“), has announced the export of nature-derived psilocybin to Australia and provided an update on its upcoming Phase IIb clinical trial. According to a news release issued by Psyence Biomed on Wednesday, July 24, 2024, it has made substantial progress in preparing for its Phase IIb study, and reported that all parties responsible for the carrying out of the study are poised to initiate the study imminently. The successful export of Psyence Biomed’s drug candidate, PEX010,...

Continue reading

Smart Cities Market to Surpass a CAGR of 25.7% by 2031 | SkyQuest Technology

Westford, USA, July 26, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the smart cities market will attain a value of $5426.3 Billion by 2031, with a CAGR of 25.7% over the forecast period (2024-2031). A smart city is a framework for implementing, creating, and advancing sustainable urban development using information and communication technology (ICT). The implementation of smart building and transportation solutions is responsible for the increase in market revenue. A smart city helps to maximize the use of available space and promotes mixed-land use for unplanned areas by utilizing hardware components such as chips, sensors, and actuators along with software solutions, including user interfaces (UIs), communication networks, and Internet of Things (IoT) devices. In addition, government initiatives and PPP plans are pushing the...

Continue reading

Notice on Convocation of the extraordinary General Meeting of Shareholders of AUGA group, AB on 20th August 2024

At the initiative and by the decision of the Board of AUGA group, AB (code 126264360, address Konstitucijos ave. 21C, Vilnius, the Company) the extraordinary general meeting of shareholders of the Company is being convened on 20th August 2024, at 10.00 a.m. The meeting will be held in the registered office of the Company, address Konstitucijos ave. 21C,  Quadrum North 12 floor, LT-08130 Vilnius, Lithuania. The registration of the shareholders begins at 9:30 a.m. Only those persons who will be shareholders of the Company at the close of the record date of the general meeting of shareholders may participate and vote at the general meeting of shareholders. The record date of the meeting shall be 12th August 2024. Agenda of the Meeting: Appointment of the auditor to audit consolidated financial statements of the Company for the year 2024...

Continue reading

CVG Announces Second Quarter 2024 Earnings Call

NEW ALBANY, Ohio, July 26, 2024 (GLOBE NEWSWIRE) — CVG (NASDAQ: CVGI) will hold its quarterly conference call on Tuesday, August 6, 2024, at 8:30 a.m. ET, to discuss second quarter 2024 financial results. CVG will issue a press release and presentation prior to the conference call. Toll-free participants dial (800) 549-8228 using conference code 11335. International participants dial (289) 819-1520 using conference code 11335. This call is being webcast and can be accessed through the “Investors” section of CVG’s website at ir.cvgrp.com where it will be archived for one year. A telephonic replay of the conference call will be available until August 20, 2024. To access the replay, toll-free callers can dial (877) 674-7070 using access code 11335#. About CVG At CVG, we deliver real solutions to complex design, engineering and manufacturing...

Continue reading

Diana Shipping Inc. Announces Signing and Drawdown of a US$167.3 Million Term Loan Facility With Nordea Bank to Refinance Two Existing Term Loan Facilities With Nordea

ATHENS, Greece, July 26, 2024 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced the successful signing of a US$167.3 million six-year secured term loan facility with Nordea Bank Abp, filial i Norge on July 25, 2024. The full amount was drawn down immediately. The new loan maturing in July 2030 is secured by ten vessels. The proceeds have been utilized to refinance two of the Company’s existing loan facilities with Nordea Bank Abp, filial i Norge: one for US$149.3 million and the other for US$18.0 million, originally maturing in October 2027 and June 2028, respectively. These loans were previously secured by twelve vessels. As part of this refinancing, two of the Company’s mortgaged vessels have...

Continue reading

Orange: Publication of Orange’s 2024 interim financial report

Press release Paris, 26 July 2024 Publication of Orange’s 2024 interim financial report Orange announces the publication of its first half 2024 financial report. The report was filed with the French Financial Markets Authority (AMF) and submitted to the U.S. Securities and Exchange Commission, and is available on the website of the Company at the following address: https://www.orange.com/en/regulated-information About Orange Orange is one of the world’s leading telecommunications operators with revenues of 39.7 billion euros in 2023 and 128,000 employees worldwide at 30 June 2024, including 72,000 employees in France. The Group has a total customer base of 285 million customers worldwide at 30 June 2024, including 246 million mobile customers and 21 million fixed broadband customers. These figures have been restated to account for...

Continue reading

Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’s

MINNEAPOLIS, July 26, 2024 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients suffering from fluid overload, today announced that the first patient has been treated with the newly launched QUELIMMUNE™ therapy in a commercial setting at Cincinnati Children’s. QUELIMMUNE, manufactured for SeaStar Medical (Nasdaq: ICU) and exclusively licensed and distributed in U.S. pediatric hospitals by Nuwellis, is a novel therapy designed to treat pediatric patients (weighing 10 kg or more) suffering from acute kidney injury (AKI) with sepsis or a septic condition and requiring kidney replacement therapy (KRT). Dr. Stuart Goldstein, Director of the Center for Acute Care Nephrology at Cincinnati Children’s, and Principal Investigator of the multi-center studies...

Continue reading

Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency

Southlake, TX, July 26, 2024 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced an analysis published by the Innovation Value Institute (IVI) titled “Introduction of AI assisted Digital Health Technology to Improve Cardiovascular Pathway Efficiency” focused on the MyoVista® wavECG™’s potential to radically improve the cardiovascular pathway efficiency. Founded in 2006, the Maynooth University, Ireland based IVI is a multidisciplinary research institute focused on digital transformation and technology adoption.  The paper analyzed the potential impact of using the MyoVista wavECG...

Continue reading

BEN Partners with Vybroo and Farmacia Roma to Offer AI-driven Audio Engagement for Brands to Build Better Relationships with Consumers

BEN’s AI technology, paired with Vybroo’s vast radio and audio network, will boost brands’ reputations with listeners by offering suggestions and highlighting opportunities JACKSON, Wyo., July 26, 2024 (GLOBE NEWSWIRE) — Brand Engagement Network (BEN), (Nasdaq: BNAI), an emerging provider of safe, personalized customer engagement AI, Vybroo, a company that connects brands with customers through innovative audio messaging strategies, and Farmacia Roma, a pharmacy chain based in Baja California, today announced a commercial agreement that will pair BEN’s and Vybroo’s unique brand-to-customer communication strategies and technologies, including BEN’s cutting-edge human-modeled AI assistants, to vastly improve customer experiences and brand engagement opportunities. Together, the companies are collaborating to merge BEN’s proprietary...

Continue reading

NN, Inc. to Hold Second Quarter 2024 Earnings Conference Call on Thursday, August 8, 2024

CHARLOTTE, N.C., July 26, 2024 (GLOBE NEWSWIRE) — NN, Inc. (NASDAQ: NNBR), a global diversified industrial company that engineers and manufactures high-precision components and assemblies, announced today that it will release its second quarter 2024 financial results for the period ended June 30, 2024, after the close of the market on Wednesday, August 7, 2024. The company will hold a related conference call on Thursday, August 8, 2024, at 10 a.m. E.T. Participants on the call are asked to register five to 10 minutes prior to the scheduled start time by dialing 1-877-255-4315 and from outside the U.S. at 1-412-317-6579. The conference call will be webcast simultaneously and in its entirety through the NN, Inc. Investor Relations website. Shareholders, media representatives and others may participate in the webcast by registering...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.